Draaijers L.J., Botman Y.A., Tempelman F.R. et al. Skin elasticity meter or subjective evaluation in scars: a reliability assessment // Burns. 2004. Vol. 30. N. 2. P. 109–114. DOI: https://doi.org/10.1016/j.burns.2003.09.003.
Ellis M.M., Jones L.R., Siddiqui F. et al. The efficacy of surgical excision plus adjuvant multimodal therapies in the treatment of keloids: a systematic review and meta-analysis // Dermatol. Surg. 2020. Vol. 46. N. 8. P. 1054–1059. DOI: https://doi.org/10.1097/DSS.0000000000002362.
Ellitsgaard V., Ellitsgaard N. Hypertrophic scars and keloids: a recurrent problem revisited // Acta Chir. Plast. 1997. Vol. 39. N. 3. P. 69–77.
Esposito G., Ziccardi P., Scioli M. et al. The use of a modified tonometer in burn scar therapy // J. Burn Care Rehabil. 1990. Vol. 11. N. 1. P. 86–90.
Fitzpatrick R.E. Treatment of inflamed hypertrophic scars using intralesional 5-FU // Dermatol. Surg. 1999. Vol. 25. P. 224–232.
Friedman S.J., Butler D.F., Pittelkow M.R. Perilesional linear atrophy and hypopigmentation after intralesional corticosteroid therapy. Report of two cases and review of the literature // J. Am. Acad. Dermatol. 1988. Vol. 19. N. 3. P. 537–541. DOI: https://doi.org/10.1016/s0190-9622(88)70209-1. PMID: 3049699.
Ginsberg B.A., Calderon M., Seminara N.M., Day D. A potential role for the dermatologist in the physical transformation of transgender people: a survey of attitudes and practices within the transgender community // J. Am. Acad. Dermatol. 2016. Vol. 74. P. 303–308.
Gold M.H. A controlled clinical trial of topical silicone gel sheeting in the treatment of hypertrophic scars and keloids // J. Am. Acad. Dermatol. 1994. Vol. 30. N. 3. P. 506–507. DOI: https://doi.org/10.1016/s0190-9622(08)81956-1. PMID: 8113473.
Goldan O., Weissman O., Regev E. et al. Treatment of postdermabrasion facial hypertrophic and keloid scars with intralesional 5-Fluorouracil injections // Aesthetic Plast. Surg. 2008. Vol. 32. N. 2. P. 389–392. DOI: https://doi.org/10.1007/s00266-007-9109-3. PMID: 18185952.
Goldman M.P., Fitzpatrick R.E. Laser treatment of scars // Dermatol. Surg. 1995. Vol. 21. N. 8. P. 685–687.
Granstein R.D., Rook A., Flotte T.J. et al. A controlled trial of intralesional recombinant interferon-gamma in the treatment of keloidal scarring. Clinical and histologic findings // Arch. Dermatol. 1990. Vol. 126. N. 10. P. 1295–1302. PMID: 2121104.
Gupta S., Kalra A. Efficacy and safety of intralesional 5-fluorouracil in the treatment of keloids // Dermatology. 2002. Vol. 204. N. 2. P. 130–132. DOI: https://doi.org/10.1159/000051830.
Jacob C.I., Dover J.S., Kaminer M.S. Acne scarring: a classification system and review of treatment options // J. Am. Acad. Dermatol. 2001. Vol. 45. N. 1. P. 109–117.
Jordan R.B., Daher J., Wasil K. Splints and scar management for acute and reconstructive burn care // Clin. Plast. Surg. 2000. Vol. 27. N. 1. P. 71–85. PMID: 10665357.
Kantor J. Reliability and photographic equivalency of the scar cosmesis assessment and rating (scar) scale, an outcome measure for postoperative scars // JAMA Dermatol. 2017. Vol. 153. N. 1. P. 55–60. DOI: https://doi.org/10.1001/jamadermatol.2016.3757.
Katz B.E. Silicone gel sheeting in scar therapy // Cutis. 1995. Vol. 56. N. 1. P. 65–67. PMID: 7555106.
Kischer C.W., Shetlar M.R., Shetlar C.L., Chvapil M. Immunoglobulins in hypertrophic scars and keloids // Plast. Reconstr. Surg. 1983. Vol. 71. N. 6. P. 821–825.
Koonin A.J. The aetiology of keloids: a review of the literature and a new hypothesis // S. Afr. Med. J. 1964. Vol. 38. P. 913–916.
Lawrence W.T. In search of the optimal treatment of keloids: report of a series and a review of the literature // Ann. Plast. Surg. 1991. Vol. 27. N. 2. P. 164–178. DOI: https://doi.org/10.1097/00000637-199108000-00012.
Mancini R.E., Quaife J.V. Histogenesis of experimentally produced keloids // J. Invest. Dermatol. 1962. Vol. 38. P. 143–181.
Mankowski P., Kanevsky J., Tomlinson J. et al. Optimizing radiotherapy for keloids: a meta-analysis systematic review comparing recurrence rates between different radiation modalities // Ann. Plast. Surg. 2017. Vol. 78. N. 4. P. 403–411. DOI: https://doi.org/10.1097/SAP.0000000000000989.
Manuskiatti W., Fitzpatrick R.E. Treatment response of keloidal and hypertrophic sternotomy scars: comparison among intralesional corticosteroid, 5-fluorouracil, and 585-nm flashlamp-pumped pulsed-dye laser treatments // Arch. Dermatol. 2002. Vol. 138. N. 9. P. 1149–1155. DOI: https://doi.org/10.1001/archderm.138.9.1149. PMID: 12224975.
Monstrey S., Middelkoop E., Vranckx J.J. et al. Updated scar management practical guidelines: non-invasive and invasive measures // J. Plast. Reconstr. Aesthet. Surg. 2014. Vol. 67. N. 8. P. 1017–1025. DOI: https://doi.org/10.1016/j.bjps.2014.04.011. Epub 2014 May 14. PMID: 24888226.
Moustafa M.F., Abdel-Fattah M.A., Abdel-Fattah D.C. The presumptive of the presumptive evidence of pregnancy estrogen on keloid growth: case report // Plast. Reconstr. Surg. 1975. Vol. 56. N. 4. P. 450–453.
Mustoe T.A., Cooter R.D., Gold M. et al. International clinical recommendations on scar management // Plast. Reconstr. Surg. 2002. Vol. 110. N. 2. P. 560–571.
Nakashima M., Chung S., Takahashi A. et al. A genome-wide association study identifies four susceptibility loci for keloid in the Japanese population // Nat. Genet. 2010. Vol. 42. N. 9. P. 768–771. DOI: https://doi.org/10.1038/ng.645.